Shareholders approve Dong-A Pharm’s split-off plan

Published: 2013-01-30 07:00:00

Updated: 2013-01-30 07:00:00

Dong-A Pharm’s shareholders gave the green light on Monday to a corporate reorganization highlighted by spinning off the company’s lucrative energy drink and over-the-counter drugs businesses.

Present shareholders of 73 percent of the firm’s stake approved Dong-A’s plan to split itself into tw...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK